Azafaros B.V., a clinical-stage biotechnology company focused on rare diseases and lysosomal storage disorders, today announced that advancements with its lead asset, nizubaglustat, will feature ...
Cycling enthusiasts ride along the "rainbow" cycling route in the Olympic ... Beijing's "Garden City" guidelines released in April, which outline long-term goals for green space integration ...
LAS VEGAS — Executives from America’s largest technology companies descended upon the HLTH conference this year with promises to lead the next round of innovations in healthcare artificial ...